February 2018

PathMaker receives funding for noninvasive device development

PathMaker Neurosystems, Boston, MA, announced it has received a funding award from the New England Pediatric Device Consortium (NEPDC) to support development of PathMaker’s MyoAmplifier™ system to treat paralysis and weakness due to damaged neuromotor pathways. The technology is an advanced noninvasive platform that integrates magnetic and electrical stimulation at cortical, spinal, and peripheral sites associated with targeted muscle. PathMaker Neurosystems is a clinical-stage bioelectronic medicine company developing noninvasive systems for the treatment of neuromotor disorders.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.